Back
Corcept Therapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
33
CORT
Corcept Therapeutics, Inc.
Last Price:
$41.75
Seasonality Move:
9.72%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corcept Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 30.8% based on the past 21 years of stock performance.
-
Corcept Therapeutics, Inc. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
-
Is Corcept Therapeutics, Inc. Stock Undervalued?The current Corcept Therapeutics, Inc. [CORT] share price is $36.31. The Score for CORT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 30.8% based on the past 21 years of stock performance.
Corcept Therapeutics, Inc. Stock Rating
Sell
33
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. overpriced?
-
Corcept Therapeutics, Inc. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
Corcept Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
117.33
52-Week Low:
32.99
Prediction Charts
Market Cap:
4.4B
Price in USD:
36.31
Volume:
1.4M
Beta:
0.78
Technical Analysis
SMA50:
68.73
SMA100:
72.71
SMA200:
72.06
52-Wk Change:
-40.58%
Stock Predictions
-
Is Corcept Therapeutics, Inc. stock public?Yes, Corcept Therapeutics, Inc. is a publicly traded company.
-
What is the Corcept Therapeutics, Inc. stock quote today?The Corcept Therapeutics, Inc. stock price is 36.31 USD today.
-
How to buy Corcept Therapeutics, Inc. stock online?You can buy Corcept Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-30 | 79.75 | 70.20 | 79.75 | 69.91 |
| Dec-31 | 38.89 | 34.80 | 39.00 | 32.99 |
| Jan-5 | 38.14 | 34.95 | 38.17 | 34.89 |
| Jan-6 | 34.84 | 35.78 | 36.90 | 34.28 |
| Jan-7 | 36.30 | 37.00 | 37.65 | 35.60 |
| Jan-8 | 36.50 | 36.53 | 37.50 | 36.13 |
| Jan-9 | 36.95 | 37.50 | 37.70 | 36.20 |
| Jan-12 | 37.44 | 37.36 | 38.11 | 37.00 |
| Jan-13 | 37.35 | 36.35 | 37.46 | 36.23 |
| Jan-14 | 36.10 | 37.04 | 37.48 | 35.71 |
| Jan-15 | 37.00 | 35.39 | 37.22 | 35.16 |
| Jan-16 | 35.39 | 34.73 | 35.86 | 34.54 |
| Jan-20 | 34.11 | 35.29 | 35.31 | 33.80 |
| Jan-21 | 35.29 | 36.31 | 37.50 | 35.00 |
Corcept Therapeutics, Inc. Earnings
Corcept Therapeutics, Inc. Earnings Report: Per Share Corcept Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics, Inc. Forecast Revenue Growth
Corcept Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $2.18 per share.
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.